Mylan’s $465 million proposed settlement with CMS may not cover the amount of money it allegedly saved by improperly classifying EpiPens as a generic drug, according to research published Monday in ...
(Reuters) - Mylan NV on Friday said it will pay $465 million to settle questions of whether it underpaid U.S. government healthcare programs by misclassifying its EpiPen emergency allergy treatment, ...
While Mylan agreed to pay $465 million to resolve accusations it improperly classified EpiPens as a generic drug, the Canonsburg, Pa.-based drugmaker has yet to finalize the settlement with the ...
Mylan and federal investigators Thursday finalized a $465 million settlement of charges the drugmaker overcharged the government for the injection allergy medication EpiPen. Resolving an issue that ...
Mylan will make its generic to EpiPen available for purchase next week, according to npr. 1. The generic will cost half as much as EpiPen, carrying a list price of $300 for a two-pack. 2. In a ...
WASHINGTON (Reuters) – Democrat Elizabeth Warren and 19 other U.S. senators voiced concern to the chief executive of Mylan NV about the high cost of its EpiPen on Tuesday, calling the device used in ...
I developed anaphylaxis without warning at seven years old. I had no idea the decision to eat a boiled egg would bring such dire consequences. But after one bite, my lips swelled to the size of a life ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results